Alex Goldberg

Nokia Corporation (NYSE:NOK) and Bristol-Myers Squibb Company (NYSE:BMY) Added to Equity Profile Report's NYSE Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/10/2014 -- Equity Profile Report expands its NYSE Active Stock Weekly Watch List adding Nokia Corporation (NYSE:NOK) and Bristol-Myers Squibb Company (NYSE:BMY).

Nokia Corporation (NYSE:NOK) operates as a mobile communications company worldwide closed down in its previous session (-0.74%) on 24,297,267 shares traded. Nokia Corporation (NYSE:NOK) is currently down (-2.08%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.

Click Here to find out what other Investors are saying about Nokia Corporation (NYSE:NOK)

Bristol-Myers Squibb Company (NYSE:BMY) a biopharmaceutical company that discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide closed up in its previous session (+3.01%) on 10,360,412 shares traded after AstraZeneca and Bristol-Myers Squibb Announced U.S. FDA Approval of Farxiga. Bristol-Myers Squibb Company (NYSE:BMY) is currently up (+63.52%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.

Click Here to find out what other Investors are saying about Bristol-Myers Squibb Company (NYSE:BMY)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com